LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
Abstract Tumor cells require high levels of cholesterol for membrane biogenesis for rapid proliferation during development. Beyond the acquired cholesterol from low-density lipoprotein (LDL) taken up from circulation, tumor cells can also biosynthesize cholesterol. The molecular mechanism underlying...
Main Authors: | Mingyue Tao, Jing Luo, Tong Gu, Xiaojuan Yu, Zhen Song, Yali Jun, Hao Gu, Kairong Han, Xiujuan Huang, Weiyong Yu, Su’an Sun, Zhengwei Zhang, Lu Liu, Xiaofei Chen, Li Zhang, Chao Luo, Qilong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-04132-6 |
Similar Items
-
Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
by: Lin T, et al.
Published: (2021-11-01) -
Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma
by: Xiang Li, et al.
Published: (2021-11-01) -
LPCAT2 controls chemoresistance in colorectal cancer
by: Alexia Karen Cotte, et al.
Published: (2018-05-01) -
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
by: Rong-Quan He, et al.
Published: (2021-08-01) -
LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
by: Hongbin Zhang, et al.
Published: (2022-01-01)